End-stage Renal Disease
📧 Sign up to get email alerts when something new happens for End-stage Renal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: Functional Reserve Estimation of Donor Kidney [Phase 4]
Phase 4 clinical trial evaluating functional reserve estimation of donor kidneys in end-stage renal disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant [Phase 2, Phase 3]
A Phase 2/3 study evaluating the safety of chronic administration of basiliximab (Simulect) in first kidney transplant recipients has been t…
-
FDA label_change · 2015-02-09FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Dianeal Low Calcium with Dextrose, updating the label for a peritoneal dialysis solution and lis…
-
FDA approval · 2015-02-09FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approves a supplemental application for Dianeal Low Calcium with Dextrose, a peritoneal dialysis solution manufactured by Vantive US Hea…
-
FDA approval · 2015-02-09FDA Approved: DIANEAL PD-2 WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Dianeal PD-2 with Dextrose, a peritoneal dialysis solution containing sodium chloride, sodium la…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-01-26Clinical Trial Update: Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension [Phase 3]
A Phase 3 clinical trial evaluating renal denervation for resistant hypertension in patients with end-stage renal disease; the trial status …
-
CLINICAL_TRIALS research · 2015-01-22Clinical Trial Update: Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial [NA]
A completed clinical trial evaluating a decision aid to improve communication about anemia treatment risks for patients with chronic kidney …
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'
A clinical trial evaluates the effectiveness of a biosimilar epoetin alfa in stable patients with end-stage renal disease–related anemia.
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Myocardial Microvascular Disease in ESRD [NA]
A terminated clinical trial sponsored by Hospices Civils de Lyon studied myocardial microvascular disease in patients with end-stage renal d…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™ [NA]
A completed clinical trial comparing nocturnal hemodialysis with short daily hemodialysis using the NxStage System One; results were posted …
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Impact of Catheter Design on Catheter Survival in Chronic Hemodialysis Patients [Phase 4]
A Phase 4 trial evaluated whether catheter design affects catheter survival in patients on chronic hemodialysis.
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism
A completed clinical trial update studying paricalcitol, a selective vitamin D receptor activator, for prevention and treatment of secondary…
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients [Phase 1, Phase 2]
Phase 1/Phase 2 trial update on quantitative mass transfer of SFP-iron from dialysate into the blood of dialysis-dependent kidney failure pa…
-
FDA approval · 2015-01-08FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
The FDA approved a supplemental application for DELFLEX, a dialysis solution containing dextrose, electrolytes, and lactate, manufactured by…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: ESTEROID WITHDRAWAL STUDY, SAFETY AND EFFICACY IN RENAL TRANPLANTATION [Phase 4]
Phase 4 trial evaluating the safety and efficacy of steroid withdrawal in kidney transplant recipients with end-stage renal disease; the stu…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Comparing an Automatic PWV Analyser to Pulse Pressure in Hemodialysis
Completed clinical trial comparing an automatic pulse wave velocity (PWV) analyser to pulse pressure in patients on hemodialysis to assess v…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers. [Phase 1]
A Phase 1 single ascending-dose study evaluating the safety, tolerability, and pharmacokinetics of intravenous soluble ferric pyrophosphate …
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Stability of Middle Molecule Clearance
A completed clinical trial assessing the stability of middle-molecule clearance during continuous hemodialysis.
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Prevalence of Protein-energy Wasting and Obesity Among Danish Dialysis Patients
This completed Danish clinical trial update reports the prevalence of protein-energy wasting (undernutrition) and obesity among dialysis pat…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis [Phase 3]
A 58-week Phase 3 trial evaluating the safety and efficacy of Ferric Citrate in patients with end-stage renal disease on dialysis for hyperp…
-
FDA approval · 2014-12-09FDA Approved: EXTRANEAL — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for Extraneal (icodextrin-containing peritoneal dialysis solution) submitted by Vantive US Healt…
-
CLINICAL_TRIALS research · 2014-12-09Clinical Trial Update: Effect of Short-term Synbiotic Treatment on Plasma P-cresol Levels in Hemodialysis Patients [Phase 4]
A Phase 4 clinical trial update evaluating whether short-term synbiotic therapy reduces plasma p-cresol levels in patients undergoing hemodi…
-
FDA approval · 2014-12-08FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
FDA approved a supplemental application for DELFLEX, a dialysis solution manufactured by Fresenius Medical Care North America.
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism [Phase 4]
A Phase 4 clinical trial update examining how Advagraf de Novo tacrolimus dosing after kidney transplantation may be tailored by recipient g…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease [Phase 3]
Phase 3 dose-ranging trial of ferric citrate (KRX-0502) in end-stage renal disease patients with hyperphosphatemia. Results from the study h…